Live Feeds

Source map — US FDA declines to approve Summit lung cancer drug after trial misses key survival goal

Every domain this feed has drawn corroborated signal from. We store facts and short excerpts and link back to originals — never republished article bodies.

SourceTypeTrust
Fierce Pharma news 60%
Reuters news 60%
Yahoo Finance news 60%
Bloomberg.com news 60%
Endpoints News news 60%
Financial Times news 60%
The New York Times news 60%
Business Wire news 60%
consent.yahoo.com news 50%
www.marketscreener.com news 50%
digg.com news 50%
ca.marketscreener.com news 50%
arynews.tv news 50%
malaysia.news.yahoo.com news 50%